Venn Life Sciences Holdings plc (VENN.L) is an Integrated Drug Development Partner offering a unique combination of drug development expertise, clinical trial design and execution services. This enables Venn to create, plan and execute drug and medical device development programs effectively and seamlessly for our clients.
Venn have dedicated operations in Ireland, France, Germany, the Netherlands, the UK, the US, and Europe-wide representation with teams across both early and late phase research. Venn’s late phase teams specialise in multi-site cross cultural clinical trials with unique knowledge of local and EU regulations. Over Venn’s 25 year history it has built up substantial therapeutic and study experience, contributing to the efficient management of sites, budgets and communication channels with all parties involved. Venn is renowned for its hands-on approach and consistent delivery of high-quality work on time and on budget.

Visit Venn Life Sciences Holdings plc at stall 39